Atlas Trials

Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve

Clinical trial NCT02113553 · TERMINATED

Trial details

NCT number
NCT02113553
Sponsor
Armando Santoro, MD
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2013-05-01
Primary completion
2016-05-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.